Literature DB >> 10925217

Progesterone effect on cell growth, ultrastructural aspect and estradiol receptors of normal human breast epithelial (HBE) cells in culture.

C Malet1, P Spritzer, D Guillaumin, F Kuttenn.   

Abstract

The stimulating effect of estradiol (E2) on breast cell growth is well documented. However, the actions of progesterone (P) and its derivatives remain controversial. Additional information is therefore necessary. On a culture system of normal human breast epithelial (HBE) cells, we observed an inhibitory effect on cell growth of a long-term P treatment (7 days) in the presence or absence of E2, using two methods: a daily cell count providing a histometric growth index, and [3H]-thymidine incorporation during the exponential phase of cell growth. A scanning electron microscopy study confirmed these results. Cells exhibited a proliferative appearance after E2 treatment, and returned to a quiescent appearance when P was added to E2. In both studies, P proved to be as efficient as the synthetic progestin R5020. Moreover, the immunocytochemical study of E2 receptors indicated that E2 increases its own receptor level whereas P and R5020 have the opposite effect, thus limiting the stimulatory effect of E2 on cell growth. In the HBE cell culture system and in long-term treatment, P and R5020 appear predominantly to inhibit cell growth, both in the presence and absence of E2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925217     DOI: 10.1016/s0960-0760(00)00061-3

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  4 in total

Review 1.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

2.  Progesterone in Peri- and Postmenopause: A Review.

Authors:  P-A Regidor
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-11       Impact factor: 2.915

3.  Oral progestagens before menopause and breast cancer risk.

Authors:  A Fabre; A Fournier; S Mesrine; J Desreux; A Gompel; M-C Boutron-Ruault; F Clavel-Chapelon
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

4.  Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells.

Authors:  Mukul Godbole; Trupti Togar; Kuldeep Patel; Bhasker Dharavath; Neelima Yadav; Sharan Janjuha; Nilesh Gardi; Kanishka Tiwary; Prachi Terwadkar; Sanket Desai; Ratnam Prasad; Hemant Dhamne; Kunal Karve; Sameer Salunkhe; Dhananjay Kawle; Pratik Chandrani; Shilpee Dutt; Sudeep Gupta; Rajendra A Badwe; Amit Dutt
Journal:  J Biol Chem       Date:  2018-10-18       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.